RESEARCH

Honrao, Chandrashekhar, Nathalie Teissier, Bo Zhang, Robert Powers, and Elizabeth M. O’Day. Gadolinium-based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-based Metabolomics. Molecules, 26(17), 5115; (2021) .https://doi.org/10.3390/molecules26175115 

 

Honrao, Chandrashekhar, Srihari Raghavendra Rao, Nathalie Teissier, S. Greg Call, Elizabeth M. O’Day, Filip Janku. Plasma-based metabolic profiling in metastatic gastrointestinal stromal tumors (GIST) [abstract]. In: Proceedings of the 112th Annual Meeting of the American Association for Cancer Research; 2021 April 10-15; Virtual. Olaris, Inc., Waltham (MA), MD Anderson Cancer Center, Houston (TX): AACR, 2021. Abstract nr LB031. https://www.abstractsonline.com/pp8/#!/9325/presentation/4540https://drive.google.com/file/d/1oFMW3kO1MyVvlfoVU5r6VmwIwdYF3LQj/view  

 

Hoyt, L. & O’Day, E. M. Perspective: A potential role for NUS in metabolite-based in vitro diagnostics. Magnetic Resonance in Chemistry 59, 257–263 (2021). https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/mrc.5104?af=R  

 

O’Day, E. M., Idos, G. E., Hill, C., Chen, J. W. & Wagner, G. Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells. OTT 11, 6827–6838 (2018). https://www.dovepress.com/cytidine-monophosphate-n-acetylneuraminic-acid-synthetase-enhances-inv-peer-reviewed-fulltext-article-OTT  

 

O’Day, E.M., K. Leitzel, A. Lipton, et al. Pretreatment serum metabolome predicts PFS in first-line trastuzumab-treated metastatic breast cancer [poster]. In: Proceedings of the 2020 San Antonio Breast Cancer Symposium; San Antonio (TX). Olaris, Inc., Waltham (MA), Penn State Hershey Medical Center, Hershey (PA): SABC, 2020. P4-10-35 

https://www.sabcs.org/Portals/SABCS2016/2020%20SABCS/ALL%20ABSTRACTS%202-9.pdf?ver=2020-12-09-104626-337 

https://04546313-eae5-4287-890e-29465e7a9a22.filesusr.com/ugd/65dee3_9469b9523e274f5cab4376373951a3c6.pdf 

 

Wolf, Josephine J., Dong, Chen & O’Day, Elizabeth M. Metabolite Biomarkers of Response (BoRs) Towards a Fingerprint for the Evolution of Metastatic Breast Cancer. Progress in Biophysics and Molecular Biology,(2021). https://www.sciencedirect.com/science/article/pii/S0079610721000985  

 

Zhang, B., Powers, R. & O’Day, E. M. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics. Metabolites 10, 203 (2020). https://www.mdpi.com/2218-1989/10/5/203  

Zhang, B., Warner, J., Pinto, C., Juric, D. & ODay, E. NMR-metabolite-resonance signature to predict HR+ breast cancer patient response to CDK4/6 inhibitors. Journal of Clinical Oncology 37, 3043–3043 (2019). https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.3043 

Zhang, B., Powers, R. & O’Day, E.M. Evaluation of Non-Uniform Sampling 2D 1H–13C HSQC Spectra for Semi-Quantitative Metabolomics [poster]: in Experimental Nuclear Magnetic Resonance Conference; 2020. Olaris, Inc, Waltham (MA),  University of Nebraska-Lincoln, Lincoln (NE): ENC, 2020. https://04546313-eae5-4287-890e-29465e7a9a22.filesusr.com/ugd/65dee3_8134fff2fd644ebe974c17e4de732a6e.pdf